[Delaying degeneration or promoting regeneration. 2 successful strategies in osteoporosis].
D000368:Aged; D015519:Bone Density / Q000187:drug effects; D002986:Clinical Trials as Topic; D005260:Female; D005598:Fractures, Spontaneous / Q000517:prevention & control*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use*; D016103:Spinal Fractures / Q000517:prevention & control*; D019379:Teriparatide / Q000627:therapeutic use*
D020845:Selective Estrogen Receptor Modulators; D019379:Teriparatide; D020849:Raloxifene Hydrochloride